CVS Group (LON:CVSG) Stock Rating Reaffirmed as Hold by Jefferies Financial Group

CVS Group (LON:CVSG)‘s stock had its “hold” rating restated by equities research analysts at Jefferies Financial Group in a research report issued to clients and investors on Friday, September 25th, Digital Look reports. They presently have a GBX 1,400 price target on the stock. Jefferies Financial Group’s target price points to a potential upside of 22.81% from the company’s previous close.

CVSG has been the subject of a number of other research reports. Shore Capital Group restated a “hold” rating and issued a GBX 1,400 price objective on shares of CVS Group in a research report on Thursday, September 24th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 1,700 target price on shares of CVS Group in a research note on Monday, July 27th. Finally, Berenberg Bank reissued a “buy” rating and issued a GBX 2,000 price target on shares of CVS Group in a report on Thursday, September 24th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, CVS Group currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 1,666.67.

CVS Group Stock Performance

CVSG traded down GBX 20 during trading on Friday, hitting GBX 1,140. The stock had a trading volume of 493,341 shares, compared to its average volume of 875,614. The firm has a market capitalization of £774.86 million, a P/E ratio of 16.55, a PEG ratio of 1.77 and a beta of 1.07. The company has a debt-to-equity ratio of 110.41, a quick ratio of 0.90 and a current ratio of 1.18. CVS Group has a twelve month low of GBX 1,062 and a twelve month high of GBX 1,648. The company’s 50-day moving average price is GBX 1,282 and its 200 day moving average price is GBX 1,227.90.

CVS Group (LON:CVSG) last issued its earnings results on Thursday, September 24th. The company reported GBX 85.60 earnings per share for the quarter. CVS Group had a net margin of 2.43% and a return on equity of 5.91%. On average, equities research analysts forecast that CVS Group will post 93.9393939 EPS for the current fiscal year.

Insider Transactions at CVS Group

In other news, insider Robin Alfonso acquired 768 shares of CVS Group stock in a transaction that occurred on Thursday, August 6th. The stock was purchased at an average cost of GBX 1,294 per share, with a total value of £9,937.92. Also, insider David Wilton bought 1,500 shares of the firm’s stock in a transaction on Tuesday, August 4th. The shares were purchased at an average price of GBX 1,276 per share, for a total transaction of £19,140. Insiders have bought 3,860 shares of company stock valued at $4,956,696 in the last quarter. 1.48% of the stock is currently owned by corporate insiders.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.